Cell and Gene Therapy, Cell Therapy, Leadership June 25, 2024 RoslinCT Appoints Professor Sir Peter Mathieson and Alexander Vos as New Non-Executive Directors
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing December 11, 2023 RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™ (exagamglogene autotemcel)
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing November 28, 2023 RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration
Cell Therapy, cGMP Manufacturing June 05, 2023 RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings
Cell Therapy April 20, 2023 Life Sciences in Scotland: How Edinburgh Technopole is Driving Innovation
Cell Therapy, eBook, Tech Transfer November 01, 2022 [EBOOK] Key Considerations for a Successful Cell Therapy Tech Transfer
Cell Therapy, Investment, Partnerships January 11, 2022 GHO Capital invests in RoslinCT, a leading cell therapy CDMO
Cell Therapy, eBook December 02, 2021 [EBOOK] Build Vs. Buy: A Critical Calculation for Cell Therapy Innovators